Gender issues

Articles from the ILO Encyclopaedia of Occupational Health and Safety

 

Vol. 1 - Pages 9.1-9.30 (Printed Version) - Tabl* 9.3

Reproductive System

STRUCTURE OF THE FEMALE REPRODUCTIVE SYSTEM AND TARGET ORGAN
VULNERABILITY

Potential female reproductive toxicants

Compound

Clinical manifestation

Site

Mechanism/target

Chemical reactivity

Alkylating
agents

Altered menses
Amenorrhoea
Ovarian atrophy

Decreased fertility
Premature menopause

Ovary

Uterus

Granulosa cell cytotoxicity
Oocyte cytotoxicity
Endometrial cell cytotoxicity

Lead

Abnormal menses
Ovarian atrophy
Decreased fertility

Hypothalamus
Pituitary
Ovary

Decreased FSH
Decreased progesterone

Mercury

Abnormal menses

Hypothalamus

Ovary

Altered gonadotrophin production and secretion
Follicle toxicity
Granulosa cell proliferation

Cadmium

Follicular atresia
Persistent diestrus

Ovary
Pituitary
Hypothalamus

Vascular toxicity
Granulosa cell cytotoxicity
Cytotoxicity

Structural similarity

Azathioprine

Reduced follicle numbers

Ovary

Oogenesis

Purine analog

Disruption of DNA/RNA synthesis

Chlordecone

Impaired fertility

Hypothalamus

Oestrogen agonist

DDT

Altered menses

Pituitary

FSH, LH disruption

2,4-D

Infertility

 

 

Lindane

Amenorrhoea

 

 

Toxaphene

Hypermenorrhoea

 

 

PCBs, PBBs

Abnormal menses

 

FSH, LH disruption

Source: From Plowchalk, Meadows and Mattison 1992. These compounds are suggested
to be direct-acting reproductive toxicants based primarily on toxicity testing in
experimental animals.

Updated by AS. Approved by JT. Last modification: 23 May 2002.